Explore our comprehensive coverage of liquid biopsy, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
The clinical validation of AI-driven multi-omics liquid biopsies is shifting oncology from reactive treatment to proactive interception. This structur...
Read Full Story →
Medical ResearchUCLA's MethylScan, published in PNAS, reads cell-free DNA methylation to detect multiple cancers and...
Medical ResearchA landmark study published in JAMA Oncology on July 3, 2026, demonstrates that circulating tumor DNA...
Public HealthIn a monumental leap for public health, the NHS has officially rolled out a revolutionary multi-canc...
BeautyThe FDA has officially approved the first AI-powered Multi-Cancer Early Detection (MCED) blood test,...
HealthcareThe FDA has officially approved the first AI-powered Multi-Cancer Early Detection (MCED) blood test,...
Formula 1The NHS has launched the Oncology Pharmacy Initiative, making free, AI-driven multi-cancer early det...
